Free Trial

Accredited Investors Inc. Acquires 1,530 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Accredited Investors Inc. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 20.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,065 shares of the healthcare conglomerate's stock after acquiring an additional 1,530 shares during the period. Accredited Investors Inc.'s holdings in UnitedHealth Group were worth $4,748,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the stock. Geode Capital Management LLC lifted its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after buying an additional 319,515 shares in the last quarter. Capital International Investors raised its stake in UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares during the period. Norges Bank bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $6,375,744,000. Northern Trust Corp increased its stake in UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares during the last quarter. Finally, Franklin Resources Inc. increased its stake in UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock worth $4,514,178,000 after acquiring an additional 861,854 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Up 1.1%

UnitedHealth Group stock traded up $3.14 during trading on Tuesday, hitting $285.28. 8,673,999 shares of the company were exchanged, compared to its average volume of 11,180,329. The company has a market capitalization of $258.78 billion, a P/E ratio of 11.95, a PEG ratio of 1.38 and a beta of 0.45. The business's 50 day moving average is $304.47 and its 200 day moving average is $432.39. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.10%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the company's stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director directly owned 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders bought 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on UNH shares. Morgan Stanley reduced their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Mizuho reduced their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. KeyCorp dropped their target price on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. Finally, Raymond James Financial cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $394.43.

View Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines